z-logo
open-access-imgOpen Access
Imatinib Treatment of Chronic Myeloid Leukemia Reveals a Preexisting CALR‐mutated Essential Thrombocythemia
Author(s) -
Blouet Anaïse,
Rousselet MarieChristine,
Le Bris Yannick,
Ribourtout Bénédicte,
Bouvier Anne,
Cottin Laurane,
JouanneauCourville Rébecca,
Blanchet Odile,
Ugo Valérie,
Luque Paz Damien
Publication year - 2018
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/hs9.0000000000000029
Subject(s) - essential thrombocythemia , polycythemia vera , myelofibrosis , thrombocytosis , leukocytosis , medicine , myeloid leukemia , myeloproliferative neoplasm , imatinib , cancer research , myeloid , fusion gene , bone marrow , gastroenterology , biology , platelet , genetics , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom